NGL Fine-Chem Limited (NSE:NGLFINE)
India · Delayed Price · Currency is INR 3,213.20
-24.20 (-0.75%)
Jul 22, 2026, 3:29 PM IST
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 20.15 billion as of July 22, 2026. Its market cap has increased by 149.02% in one year.
Market Cap
20.15B
Enterprise Value
20.79B
Revenue
5.01B
Ranking
n/a
PE Ratio
41.87
Stock Price
3,213.20
ChartMarket Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 20.15B, an increase of 24,962.49%. That is a compound annual growth rate of 29.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 20.15B | 131.48% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.71T |
| Divi's Laboratories | 1.95T |
| Apollo Hospitals Enterprise | 1.28T |
| Cipla | 1.16T |
| Indoco Remedies | 22.69B |
| Ind-Swift Laboratories | 20.60B |
| Sakar Healthcare | 19.55B |
| Windlas Biotech | 18.17B |